Cite
HARVARD Citation
Miller, C. et al. (n.d.). P445 Does The Sequence Matter ? Comparative effectiveness of a second line biologic in patients with Ulcerative Colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab. Journal of Crohn's and colitis. pp. S443-S444. [Online].